Search research articles
Contact Us
Filters
Showing results (71-80 of 144) with videos related to
Page
of 15
Sort By:
Journal of Parkinson'S Disease
|
August 28, 2019
Predicting Progression in Parkinson's Disease Using Baseline and 1-Year Change Measures
Lana M Chahine, Andrew Siderowf, Janel Barnes, et al.
Clinical and Translational Science
|
July 28, 2017
Dopamine Transporter Neuroimaging as an Enrichment Biomarker in Early Parkinson's Disease Clinical Trials: A Disease Progression Modeling Analysis
Daniela J Conrado, Timothy Nicholas, Kuenhi Tsai, et al.
The Lancet. Neurology
|
July 21, 2023
Safety and efficacy of venglustat in GBA1-associated Parkinson's disease: an international, multicentre, double-blind, randomised, placebo-controlled, phase 2 trial
Nir Giladi, Roy N Alcalay, Gary Cutter, et al.
Clinical and Translational Science
|
February 2, 2019
Molecular Neuroimaging of the Dopamine Transporter as a Patient Enrichment Biomarker for Clinical Trials for Early Parkinson's Disease
Klaus Romero, Daniela Conrado, Jackson Burton, et al.
Annals of Neurology
|
April 27, 2026
Insights Gained From the PPMI Brain Donation Program
Tatiana Foroud, Laura E A Heathers, Syed Bukhari, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
August 20, 2009
A longitudinal program for biomarker development in Parkinson's disease: a feasibility study
Bernard Ravina, Caroline Tanner, Diane Dieuliis, et al.
Annals of Neurology
|
May 6, 2026
Biologic Frameworks for Synucleinopathies: Contributions of the Parkinson's Progression Markers Initiative
Lana M Chahine, Roy N Alcalay, Ethan G Brown, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
April 4, 2017
The prodromal phase of leucine-rich repeat kinase 2-associated Parkinson disease: Clinical and imaging Studies
Claustre Pont-Sunyer, Eduardo Tolosa, Chelsea Caspell-Garcia, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 13, 2019
Tau PET imaging with <sup>18</sup>F-PI-2620 in Patients with Alzheimer Disease and Healthy Controls: A First-in-Humans Study
Andre Mueller, Santiago Bullich, Olivier Barret, et al.
NPJ Parkinson'S Disease
|
October 22, 2022
Longitudinal clinical and biomarker characteristics of non-manifesting LRRK2 G2019S carriers in the PPMI cohort
Tanya Simuni, Kalpana Merchant, Michael C Brumm, et al.
Page
of 15
Search research articles
Search
Showing results (71-80 of 144) with videos related to
Sort By:
Page
of 15
Journal of Parkinson'S Disease
|
August 28, 2019
Predicting Progression in Parkinson's Disease Using Baseline and 1-Year Change Measures
Lana M Chahine, Andrew Siderowf, Janel Barnes, et al.
Clinical and Translational Science
|
July 28, 2017
Dopamine Transporter Neuroimaging as an Enrichment Biomarker in Early Parkinson's Disease Clinical Trials: A Disease Progression Modeling Analysis
Daniela J Conrado, Timothy Nicholas, Kuenhi Tsai, et al.
The Lancet. Neurology
|
July 21, 2023
Safety and efficacy of venglustat in GBA1-associated Parkinson's disease: an international, multicentre, double-blind, randomised, placebo-controlled, phase 2 trial
Nir Giladi, Roy N Alcalay, Gary Cutter, et al.
Clinical and Translational Science
|
February 2, 2019
Molecular Neuroimaging of the Dopamine Transporter as a Patient Enrichment Biomarker for Clinical Trials for Early Parkinson's Disease
Klaus Romero, Daniela Conrado, Jackson Burton, et al.
Annals of Neurology
|
April 27, 2026
Insights Gained From the PPMI Brain Donation Program
Tatiana Foroud, Laura E A Heathers, Syed Bukhari, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
August 20, 2009
A longitudinal program for biomarker development in Parkinson's disease: a feasibility study
Bernard Ravina, Caroline Tanner, Diane Dieuliis, et al.
Annals of Neurology
|
May 6, 2026
Biologic Frameworks for Synucleinopathies: Contributions of the Parkinson's Progression Markers Initiative
Lana M Chahine, Roy N Alcalay, Ethan G Brown, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
April 4, 2017
The prodromal phase of leucine-rich repeat kinase 2-associated Parkinson disease: Clinical and imaging Studies
Claustre Pont-Sunyer, Eduardo Tolosa, Chelsea Caspell-Garcia, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 13, 2019
Tau PET imaging with <sup>18</sup>F-PI-2620 in Patients with Alzheimer Disease and Healthy Controls: A First-in-Humans Study
Andre Mueller, Santiago Bullich, Olivier Barret, et al.
NPJ Parkinson'S Disease
|
October 22, 2022
Longitudinal clinical and biomarker characteristics of non-manifesting LRRK2 G2019S carriers in the PPMI cohort
Tanya Simuni, Kalpana Merchant, Michael C Brumm, et al.
Page
of 15